Bluebird Ventures
Startup rounds since 2012 with a Bluebird Ventures investor on the board, and the firm's own fund filings.
Raises
9
since 2012
Unannounced
1
no announcement found, of those filed since 2025
Funds
1
fund filings under the firm's name
Rounds
- Savanna Biotherapeutics, Inc.$13M
- NovoGlia, Inc.$24.3M
- Forty Seven, Inc.$75M
- Merganser Biotech, Inc.$13.1M
- Forty Seven, Inc.$34.1M
- Theracos Inc$25M
- Virobay Inc$18M
- Horizon Pharma, Inc.$65.9M
- Horizon Pharma, Inc.$32.8K
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2025 | 1 | 1 |
| 2022 | 1 | — |
| 2017 | 1 | — |
| 2016 | 3 | — |
| 2014 | 1 | — |
| 2012 | 2 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Bluebird Ventures I, L.P. | 14 Jun 2019 | $104M | $104M |
Listed because a Bluebird Ventures fund's filing names a director of each company. A name match is not a verified identity.